PURIFICATION OF SPERGUALIN-RELATED COMPOUNDS

Abstract: Spergualin-related compounds and their synthetic inter­ mediates are purified by electrodialysis and/or reverse osmosis. Solutions of such compound or intermediate containing inorganic salt (due to elution with inorganic salt solution) can be desalinated by electrodialysis and then concentrated by reverse osmosis.

Description: The present invention relates to the purification of spergualin-related compounds which are useful as antitumor or immunosuppressive substances, and of their synthetic intermediates. Spergualin is a antitumor antibiotic discovered by H. Umezawa et al (Japanese Patent Kokai No. 48957/82), and many derivatives and analogues of spergualin have been reported (Japanese Patent Kokai No. 62152/83, No. 42356/84, No. 185758/85, and No. 48660/87). In addition, the immunosuppressive activity of spergualin and its related compounds has been reported (Japanese Patent Kokai No. 129119/86). These spergualin-related compounds are produced by cultivation, semi-synthesis, or total synthesis. Among spergualin, its derivatives, and its analogues (hereinafter referred to as spergualin-related compounds), spergualin and 15-deoxyspergualin, which have excellent biological activity, are relatively unstable, and so it has been extremely difficult to produce a large amount of sample of high quality. Spergualin-related compounds, their synthetic intermediate, glyoxylylspermidine, and their derivatives readily decompose on concentration by heating. There are problems in removing inorganic salt from active fractions and/or in concentrating fractions containing spergualin-related compounds eluted from ion-exchange and porous absorbent resin columns by aqueous inorganic salts. In concentration and desalination, evaporation or freeze-drying and extraction with organic solvent have been avoidable steps, because other processes suitable for spergualin-related compounds were not available. Thus, to help prevent degradation, concentration had to be at low temperature with small portion or by freeze-drying, reducing productivity. A process that includes such a concentration step is not useable for industrial-scale production. Since the known processes of concentration and/or desalination were not applicable to large-scale production, effective and economical methods have been needed. Chemical Engineering Progress vol. 80, no. 12, December 1984, pages 47 to 50, discloses the purification of protein solutions by electrodialysis. Chemical Abstracts, vol. 97, no. 7, August 16, 1982, page 508, abstract 54185 discloses the desalination of soya bean hydrolisates by electrodialysis. Chemical Abstracts, vol. 104, no. 22, June 2, 1986, page 443, abstract 193230x, discloses the concentration of β-lactum antibiotic solution by reverse osmosis. Chemical Abstracts, vol. 87, no. 24, December 12, 1977, page 310, abstract 189423a discloses the concentration of antibiotics by reverse osmosis. According to the invention there is provided a process for the purification of spergualin-related compounds of the formula I; in which: R₁ is -(CH₂)₄-, -(CH₂)₆-, or R₂ IS -(CH₂)₂-, -CH(OH)CH₂- or -CH=CH-; R₃ is -CH(OH)-, -CH(OCH₃)-, -CH₂- or -CH(CH₂OH)-; and X is hydrogen or an amino acid or peptide from which the hydroxy group of the carboxyl group has been removed, or pharmaceutically acceptable salts thereof and their synthetic intermediate of formula II; comprising: subjecting a solution containing a compound according to formula I or II to electrodialysis, reverse osmosis or both electrodialysis and reverse osmosis. We have found that desalination can effectively be achieved by electrodialysis of solutions containing spergualin-related compounds (or their synthetic intermediate) and inorganic salt. As well as salts, acids or bases can be removed by electrodialysis if desired; compounds with low molecular weight such as spergualin-related compounds and their synthetic intermediate, which have positively charged functional groups such as amino or guanidino groups, can be recovered in high yield. We have also found that concentration of solutions containing spergualin-related compounds and their intermediate can effectively be achieved by reverse osmosis, during which degradation of said compounds is greatly decreased; recovery of compounds with low molecular weight, such as spergualin-related compounds and their intermediate, can be high. Specific examples of spergualin-related compounds are: 1) N-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidinoheptanamide)-2-hydroxyethanamide (15-deoxyspergualin) 2) N-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidinoheptanamide)-2-methoxyethanamide 3) N-[4-(3-aminopropyl)aminobutyl]-2-(9-guanidinononanamide-2-hydroxyethanamide (4) N-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidinoheptanamide)-ethanamide (5) N-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidinoheptanamide)-(S)-2-hydroxymethylethanamide (6) N-[4-(3-aminopropyl)aminobutyl]-2-[4-(p-guanidinophenyl)-butan amide]-ethanamide (7) N-[4-(3-aminopropyl)aminobutyl]-2-[4-(p-guanidinophenyl)-butan amide]-(S)-2-hydroxymethylethanamide (8) N-[4-(3-aminopropyl)aminobutyl]-2-[3-(p-guanidinomethyl-phenyl)-propanamide]-(S)-2-hydroxymethylethanamide (9) N-[4-(3-aminopropyl)aminobutyl]-2-[3-(p-guanidinophenyl)-pentanamide]-(S)-2-hydroxymethylethanamide (10) N-[4-(3-aminopropyl)aminobutyl]-2-(7-guanidino-hept-2-enamide)-2-methoxyethanamide (11) N-[4-(3-aminopropyl)aminobutyl]-2-(9-guanidino-nona-2-enamide)-2-hydroxyethanamide (12) spergualin (13) N-[[4-[3-((D,L,DL)-phenylglycyl)aminopropyl]aminobutyl]]-2-(7-guanidinoheptanamide)-(S)-2-hydroxymethylethanamide (14) N-[[4-[3-((L)-leucyl-(L)-leucyl)aminopropyl]aminobutyl]]-2-(7-guanidinoheptanamide)-(S)-2-hydroxymethylethanamide These compounds have the chemical structures shown in Table 1. Spergualin-related compounds and their synthetic intermediate mentioned above may be produced by methods described in Japanese Patent Kokai Nos.62152/83, 42356/84, 185758/85 and 48660/87. A solution containing product obtained by these methods is purified by ion-exchange and/or porous absorbent resin column chromatography using a solution of inorganic salt (for example, sodium chloride) as eluant. The concentration of spergualin-related compounds and/or their synthetic intermediate in the solution is usually of from 0.1 to 10% by weight, and that of salt (which can be chosen freely) from 0.1 to 10% by weight. Such solutions are obtainable by column chromatography using various ion-exchange resins or porous absorbent resins - e.g. cation-exchange resins such as CM-Sephadex, Diaion SK-resins, and Diaion WK-resins or absorbent resins such as the Diaion HP series and Sepabeads SP series. According to the present invention, the solution is desalted and/or concentrated by means of electrodialysis and/or reverse osmosis. The principle of electrodialysis is as follows. A continuous current is made to pass through alternate layers of cation-exchange membrane which has negative charge (e.g. from sulfonyl or carboxyl groups) and anion-exchange membrane which has positive charge (e.g. from quaternary ammonium or amino groups). The driving force of electrodialysis is the potential difference between the electrodes at the two terminals. The electric charge on the membranes impedes or facilitates the movement of the ions being so treated. Cations penetrate the cation-exchange membrane, which has a negative charge, but anions cannot because they are repelled by the negative charge; the opposite is the case for the anion-exchange membrane, which has a positive charge, so that anions penetrate this membrane but cations cannot. These different ion-exchange membranes thus have selective effects on ions of opposite charges. For example, when sodium chloride is treated by electrodialysis, desalination occurs when the sodium ions pass through the ion-exchange membrane to the negative pole, while the chlorine ions pass through the ion-exchange membrane to the positive electrode. To prevent the dialysis of substances which have positive functional groups such as amino groups, guanidino groups, and which have the relatively low molecular weights (about 1000 or less) of spergualin-related compounds and their synthetic intermediate , and it is necessary to dialyze selectively only the dissociated ions of the salts which are desired to be removed. Ion-exchange membranes having these properties are called membranes for selective dialysis or permselective membranes. Recently, a variety of ion-exchange membranes which have permselectivity for ions of the same charge have been developed. A number of methods have been proposed to impart ion permselectivity to membranes, classifiable roughly as 1) increasing the degree of crosslinking, resulting in a dense structure, and 2) induction of an opposite charge on the surface. By adjustment of the size of the pores in the membrane, it is possible to regulate the permeation of the substances being treated according to differences in their molecular weight; or by the provision of a thin layer with a charge opposite to that of the main body of the ion-exchange membrane on the surface of the membrane, it is possible to select between ions with mono- and di-valence. Also, such a thin layer acts to increase the recovery of charged organic compounds of low molecular weight. Ion-exchange membranes which can be used in purification according to this invention are widely known; for example, it is possible to use any of the membranes listed in Table 2, quoted from page 216 of Recent Membrane Techniques and their Applications , published August 1984 (in Japanese) by the Fuji Techo System Co., Ltd., with the membrane being selected according to its intended use. Based on the principles described above, ion-exchange membranes for which selectivity has been increased by surface treatment are particularly desirable. The reason is that because of the positive charge of either the amino or the guanidino group of the spergualin-related compounds or their synthetic intermediate , these compounds generally adsorb onto the membrane, and the phenomenon of breakthrough into the outer solution takes place; surface treatment is for preventing the effectiveness of the desalination from declining, and to avoid decrease in recovery. A particularly suitable combination of ion-exchange membranes is, for example, the Asiplex [phonetic] cartridge AC-110 of the Asahi Chemical Industry Co., Ltd., but there is no particular limitation on what may be used, and to achieve the purpose of this invention, it is possible to use products that are based on such ion-exchange membranes and that have increased capacity, that have been modified, or that have been reconstructed. It is possible to use any of the various kinds of electrodialysis apparatus that are commercially available. For example, very satisfactory results can be obtained with electrodialysis apparatus equipped with ion-exchange membranes of the AC-110 type from Asahi Chemical Industry Co., Ltd., with very little breakthrough of the spergualin-related compounds or their synthetic intermediates into the outer solution, and with removal of inorganic salts. As a rule, the desalination capacity of an electrodialysis device is governed by the surface area of the ion-exchange membrane; in this invention as well, the apparatus is to be used with ion-exchange membranes having a surface area suited to the scale of the planned use. Examples of salts which can be removed include sodium chloride, potassium chloride, lithium chloride, calcium chloride, magnesium chloride, potassium bromide, sodium bromide, lithium bromide, calcium bromide, magnesium bromide, potassium acetate, sodium acetate, lithium acetate, calcium acetate, magnesium acetate, potassium formate, sodium formate, lithium formate, calcium formate, magnesium formate, potassium carbonate, sodium carbonate, lithium carbonate, calcium carbonate, magnesium carbonate, potassium phosphate, sodium phosphate, lithium phosphate, calcium phosphate, magnesium phosphate, potassium sulfate, sodium sulfate, lithium sulfate, calcium sulfate, magnesium sulfate, and the like. Examples of the acids and bases which can be removed include hydrochloric acid, hydrobromic acid, acetic acid, formic acid, carbonic acid, phosphoric acid, sulfuric acid, as well as potassium hydroxide, sodium hydroxide, lithium hydroxide, magnesium hydroxide, calcium hydroxide. The principles of the reverse osmosis process to be used in this invention are as follows. A semipermeable membrane, which can be penetrated by a solvent (usually water) but not by the solute, is used. Pressure is applied to the solution in opposition to the osmotic pressure, which promotes permeation in the direction opposite to that in which the solvent would generally move, giving rise to reverse osmosis, by which means the solute and the solvent can be separated. The driving force in reverse osmosis is the difference in pressure. This semipermeable membrane is called also a membrane for reverse osmosis, and it is generally made of natural high molecular cellulose acetate or synthetic high molecular weight substance. As the raw material for the synthetic macromolecule, there may be used polyether amide, polyether urea, aromatic polyamide, sulfonated polyfurfuryl alcohol, polybenzimidazole, polypiperazine amide, sulfonated polysulfone, sulfonated phenylene oxide, polyethyleneimine-toluenediisocyanate, polyethyleneimine-acid chloride, polyamide carbonate, polybenzimidazolone, polyimide, polyether, denatured polyacrylonitrile, polyethyleneimine. As such semipermeable membranes, flat membranes, spirals, tubes, and hollow fibers are now commercially available as modules for reverse osmosis. The properties of a module for reverse osmosis are evaluated in terms of the extent of exclusion of solute and the amount of solvent (water) which passes through the membrane. In this invention, it is preferable to use modules with a high rate of removal suitable for concentration of organic compounds of low molecular weight; moreover, these modules should be permeable by large amounts of water at a relatively low pressure. Module membranes for use in reverse osmosis which are commercially available are exemplified in Table 3. The membrane for reverse osmosis to be used in concentration according to this invention can be selected from these commercially available products; particularly suitable membranes include the PEC-1000 (Toray Industries, Inc.), Hollosep (Toyobo Co., Ltd. ), and NTR-7100 series (Nitto Denko Corporation). With this kind of reverse osmosis, it is possible to use any of the commercially available apparatus for reverse osmosis in which are incorporated the kinds of modules for reverse osmosis described above for the concentration of spergualin-related compounds and their synthetic intermediate There is no restriction as to the apparatus to be used provided that the purpose of this invention is achieved. As a rule, the capacity of such apparatus to concentrate substances depends on the effective surface area of the membrane for reverse osmosis, so apparatus with membrane modules with a surface area suitable for the scale of the planned use for this invention can be selected. Preferably, when the eluate to be concentrated contains inorganic salt desalination is carried out, and after the osmotic pressure arising from the inorganic salt has been lowered, concentration by reverse osmosis is performed. For the desalination process, the electrodialysis method described above is most satisfactory. Thus, for the purification of spergualin-related compounds and their synthetic intermediate , it is possible to use electrodialysis for the desalination process and reverse osmosis for the concentration process depending on the purpose in mind, and these can be used separately or in combination one after the other. EXAMPLES This invention will be explained in detail by reference to examples and by referring to the accompanying drawings wherein Fig. 1 is a graph which shows the test results of desalination by means of electrodialysis, with time as the abscissa and electroconductivity and yield as ordinates, but this invention is not to be taken to be limited to these particular examples. Example 1 Electrodialysis was performed in an electrodialyser (Microasilyzer [phonetic] G-3, Asahi Chemical Industry Co., Ltd.) equipped with an ion-exchange membrane (Asiplex [phonetic] cartridge AC-110-400, Asahi Chemical Industry Co., Ltd.) with an effective membrane surface area of 400 cm² with 500 mℓ of a 1 M NaCl solution that contained 5 g of glyoxylylspermidine-2HCl as the sample solution and with 400 mℓ of tap water as the outer fluid. The salt concentration of the sample solution was monitored in terms of the electroconductivity, mS/cm, of the solution. At the same time, the sample concentration was measured by high-pressure liquid chromatography. The results of the tests are shown in Table 4 and Figure 1. Desalination was complete in about 60 minutes. By concentration under reduced pressure, 4.95 g of glyoxylylspermidine-2HCl was recovered from the sample solution (yield, 99%). Microasilyzer G3/AC-110-400 Time (min) Electroconductivity (mS/cm) pH Yield (%) 0.0 85.1 6.3 100 10.0 72.6 6.2 20.0 48.0 6.1 30.0 22.1 6.1 40.0 10.5 6.2 100 50.0 7.56 6.3 60.0 6.65 6.36 99 Example 2 Electrodialysis was performed in an electrodialyser (Microasilyzer G-3, Asahi Chemical Industry Co., Ltd.) equipped with an ion-exchange membrane (cartridge AC-110-400, Asahi Chemical Industry Co., Ltd.) with an effective membrane surface area of 400 cm² with 500 mℓ of a 1 M NaCl solution that contained 5 g of 15-deoxyspergualin-3HCl as the sample solution and with 400 mℓ of tap water as the outer fluid. The salt concentration of the sample solution was monitored in terms of the electroconductivity (mS/cm) of the solution. At the same time, the sample concentration was measured by high-pressure liquid chromatography. Desalination was complete in about 60 minutes. By concentration under reduced pressure, 4.7 g of 15-deoxyspergualin-3HCl was recovered from the sample solution (yield, 94%). Example 3 Pressure of 55 kg/cm² was applied to 60 ℓ of an aqueous solution of 600 g of glyoxylylspermidine-2HCl in an apparatus for reverse osmosis equipped with Hollosep HR 5155 (Toyobo Co., Ltd.). In an operation time of 37 minutes, 50 ℓ of dialyzed liquid was obtained. In this dialyzed liquid, glyoxylylspermidine was not detected. The concentrated liquid and the washing liquid were pooled, giving 11.5 liters (concentration was 5.2-fold, with 98.3% recovery of glyoxylylspermidine). The volume of dialyzed liquid, the pressure, and the recovery of glyoxylylspermidine-2HCl with time are shown in Table 5. Concentration of glyoxylylspermidine by reverse osmosis Operation time (min,sec) Pressure(Kg/cm²) Dialyzed fluid Yield(%) P₁ P₂ Flux(ℓ/min) Total volume(ℓ) 0 55 55 1.55 0 100 7.10 55 55 1.42 10 14.20 55 55 1.45 20 99 21.30 55 55 1.45 30 29.30 55 57.5 1.40 40 98.5 37.00 55 55 0.82 50 98.3 Example 4 Pressure of 55 kg/cm² was applied to 30 ℓ of an aqueous solution of 300 g of 15-deoxyspergualin-3HCl in an apparatus for reverse osmosis equipped with Hollosep HR5155 (Toyobo Co., Ltd.). In an operation time of 18 minutes, 25 ℓ of dialyzed liquid was obtained. In this dialyzed liquid, 15-deoxyspergualin was not detected. The concentration liquid and the washing liquid were pooled, giving 7 liters (concentration was 4.3-fold, with 99% recovery of 15-deoxyspergualin). Example 5 Electrodialysis was performed in an electrodialyser (Microasilyzer G-3, Asahi Chemical Industry Co., Ltd.) equipped with an ion-exchange membrane (cartridge AC-110-400, Asahi Chemical Industry Co., Ltd.) with an effective surface area of 400 cm² with 500 mℓ of a 1 M NaCl solution that contained 5 g of 15-deoxyspergualin-3HCl as the solution for permeation and with 400 mℓ of tap water as the outer fluid. By this procedure, 400 mℓ of sample solution was obtained, and this solution was treated by reverse osmosis in a filter device for reverse osmosis equipped with a flat membrane (membrane diameter, 76mm) of NF-70 Nanofilm (Film Tech) by the application of 15 kg/cm² pressure by means of N₂ gas for filtration. After 70 minutes at this pressure, 320 mℓ of dialyzed liquid was obtained, and 80 mℓ of concentrated liquid was recovered (concentration was 5-fold, with 93.5% recovery of 15-deoxyspergualin). This invention thus provides the use of a desalination step by electrodialysis and/or a reverse-osmosis step, by which it is possible to prepare spergualin-related compounds in the highly purified form needed for their use in pharmaceutical preparations, and this information furthermore provides a means by which such purification can be done efficiently and economically. The efficiency of this invention is obvious by the fact that it took only 3 days to achieve the processes of desalination and concentration for the manufacture of spergualin-related compounds and their synthetic intermediates in kilogram-scale, while by the conventional method that involves concentration by freeze-drying and extraction with organic solvent, it took 13 days.

Claims: A process for the purification of spergualin-related compounds of the formula I; in which: R₁ is -(CH₂)₄-, -(CH₂)₆-, or R₂ is -(CH₂)₂-, -CH(OH)CH₂- or -CH=CH-; R₃ is -CH(OH)-, -CH(OCH₃)-, -CH₂- or -CH(CH₂OH)-; and X is hydrogen or an amino acid or peptide from which the hydroxy group of the carboxyl group has been removed, or pharmaceutically acceptable salts thereof and their synthetic intermediate of formula II; comprising: subjecting a solution containing a compound according to formula I or II to electrodialysis, reverse osmosis or both electrodialysis and reverse osmosis.

Inventors: KATO, IKUNOSHIN, KUROME, TORU, MIYAZAKI, KEIKO, MORIGUCHI, MAKOTO, SAINO, TETSUSHI, UMEDA, YOSHIHISA
Applicants: NIPPON KAYAKU KABUSHIKI KAISHA, TAKARA SHUZO CO. LTD.
Application year: 1989
Main classification: C07C277
IPC codes: C07C277, C07C279, C07C231, C07B63, C07C235